{
    "2020-10-30": [
        [
            {
                "time": "2020-11-09",
                "original_text": "Overconfident Predictions for Stocks, the Election, and a Covid-19 Vaccine",
                "features": {
                    "keywords": [
                        "overconfident",
                        "predictions",
                        "covid-19 vaccine"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-15",
                "original_text": "Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit",
                "features": {
                    "keywords": [
                        "merger",
                        "mylan",
                        "pfizer",
                        "upjohn"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-20",
                "original_text": "U.K. regulator is accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report",
                "features": {
                    "keywords": [
                        "uk regulator",
                        "accelerating",
                        "covid-19 vaccines",
                        "pfizer",
                        "astrazeneca"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-25",
                "original_text": "Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn",
                "features": {
                    "keywords": [
                        "mylan",
                        "pfizer",
                        "ftc clearance",
                        "combination"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-30",
                "original_text": "How Novavax Has a 2-Pronged Approach to Vaccine Sales",
                "features": {
                    "keywords": [
                        "novavax",
                        "vaccine sales",
                        "approach"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-05",
                "original_text": "Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study",
                "features": {
                    "keywords": [
                        "pharma stock",
                        "q3 earnings",
                        "resumption",
                        "vaccine study"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-10",
                "original_text": "Novavax lays out specific minority targets for U.S. COVID-19 vaccine trial",
                "features": {
                    "keywords": [
                        "novavax",
                        "minority targets",
                        "vaccine trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-15",
                "original_text": "U.S. approves combination of Pfizer's Upjohn and Mylan",
                "features": {
                    "keywords": [
                        "us approves",
                        "pfizer",
                        "upjohn",
                        "mylan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-20",
                "original_text": "The Zacks Analyst Blog Highlights: UnitedHealth Group, Adobe, Pfizer, Intel and T-Mobile US",
                "features": {
                    "keywords": [
                        "zacks analyst",
                        "unitedhealth",
                        "adobe",
                        "pfizer",
                        "intel",
                        "t-mobile us"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "telecommunications"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-25",
                "original_text": "UK starts accelerated reviews for COVID-19 vaccines from AstraZeneca and Pfizer - Bloomberg",
                "features": {
                    "keywords": [
                        "uk starts",
                        "accelerated reviews",
                        "covid-19 vaccines",
                        "astrazeneca",
                        "pfizer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-30",
                "original_text": "What's the Outlook for BioNTech Stock?",
                "features": {
                    "keywords": [
                        "outlook",
                        "biontech stock"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}